FDA Should Loosen Leash On Responding To Off-Label Info Requests, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
The standard in a recent FDA draft guidance for how companies should respond to unsolicited public requests for off-label product information is too restrictive, firms say.